Ranbaxy sees $100 mn revenue from South Africa ops in 2010

Indian drugmaker Ranbaxy expects $100 million in revenue from its South African operations in 2010, the firm's chief executive said on Thursday. The company, majority owned by Japan's Daiichi Sankyo, had revenue of about $75 million from its South African operations in 2009, Atul Sobti said. The company will begin manufacturing operations soon in South Africa, which is one of its top-five markets, he said.